Weight Loss Products: Immediate Public Notification: Undeclared Drug Ingredients
Products may substantially increase blood pressure and/or pulse rate in some patients.
Products may substantially increase blood pressure and/or pulse rate in some patients.
Injected particulate could result in blocked administration of the drug to the patient, causing a delay in therapy.
Safety Labeling Changes includes 37 products with revisions to Prescribing Information. Posted 06/13/2014.
Il Comitato di Valutazione dei rischi per la farmacovigilanza (PRAC) ha
iniziato una revisione per valutare il rischio cardiovascolare dei
medicinali contenenti ibuprofene ad uso sistemico (ovvero quelli presi
per bocca ma non per via topica come creme o gel).
FDA advises consumers to avoid all products offered over-the-counter (OTC) for chelation or detoxification.
One lot of 3.0mm sized connectors were placed in packages labeled as 3.5mm.
Delayed or inappropriate treatment of hyperglycemic or hypoglycemic states due to missed/delayed detection could
lead to serious health consequences, including death.
Cancer-causing risk in addition to increased blood pressure and/or pulse rate.
80.211.154.110